Another miRNA, miR-506, has been shown to inhibit ovarian cancer progression by directly targeting the integrins ITGA6 and ITGB3, both of which are implicated in ovarian cancer cell migration, invasion, and survival [66]. Here, ITGB3 is linked to ovarian carcinoma.